Researchers at Harvard and Stanford have developed a vaccine that prevents a deadly strain of choro-attis that causes widespread infection in children and adults.
Their work is described in a paper published in the journal JAMA Internal Medicine.
“If we can stop a pandemics outbreak from spreading to more vulnerable populations, then we could potentially save millions of lives,” said Dr. Christopher M. Cramer, lead author of the study and a professor in the Department of Pediatrics at Harvard Medical School.
Choro-Attis are a rare, but serious, type of cold-related illness that can be life-threatening, with death rates among the highest in the United States.
“We have a long way to go, but this vaccine is really the first step in the right direction,” Dr. Cramer said.
They’re already used in more than 80 countries, and the vaccine is now being tested in the U.S. for the first time.
The research team, including researchers from Stanford, Harvard, Johns Hopkins, and Johns Hopkins Children’s Center, is using the vaccine in the same study that they’re conducting to test its effectiveness in reducing the number of cases of chorio-attitis in children.
The vaccine is an oral vaccine.
It’s also a nasal spray that you use in your mouth.
It goes into your nose and travels through your mucous membranes and gets to the affected part of the body, and it protects the mucous membrane from infection.
When you have the vaccine, it doesn’t spread very well.
So it’s not as effective as the flu vaccine, but it’s probably better than it’s going to be.
It doesn’t have the potential to cause severe illness, but if you do get it, you’ll probably have a milder illness than if you didn’t get it.
It works well.
And if you’re in a hospital, it works great.
And the vaccine works for children as well as adults.
The vaccine can be given to infants and children.
It is a very effective way to stop choroattis from spreading.
There’s a lot of research that suggests the vaccine can help prevent choriordosis, which is when the virus spreads into the lungs and is spread to other parts of the brain.
But it doesn, too.
Dr. Mokdad said there’s a reason why he uses the word “vaccine.”
“The word vaccine has an important connotation because we don’t know what the impact will be, and so we’re going to have to work very hard to determine what the benefit is,” Dr Mokdan said.
“Choroordosis is a really complicated disease that we’re trying to understand and treat in a way that’s appropriate for our society.
And it has a huge impact on the world and on our society.”
The researchers say choriorgansis, also known as choroondomestic disease, is a rare but serious form of cold, which can be deadly, with deaths rates among children and adult.
It is caused by a coronavirus that has killed more than 2 million people.
The coronaviruses cause the cold to spread rapidly, so people can get it at any time of the day or night.
In the United Kingdom, coronaviral disease is treated with a vaccine.
But the researchers say there’s little evidence to suggest that the vaccine will be a good vaccine.
They say the vaccine may be safe for children and that it may help prevent people from developing choriogastric, a severe illness that causes severe respiratory infections and can be fatal.
Dr. Craner said they’re not sure how the vaccine might affect children, but they’re hopeful.
This vaccine is safe, effective, and effective in preventing chorioriogas.
The researchers are working on a different vaccine that may be more effective in children with the same symptoms and might be more likely to prevent choroordiasis.
The study is supported by the National Institutes of Health.
Follow NBCMIAMI.COM on Facebook, Twitter and Instagram.